{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:44:34Z","timestamp":1757450674041,"version":"3.40.5"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>The collagenase of the bacterium Clostridium histolyticum (CCH) is already an established treatment for fibroproliferative diseases like M. Dupuytren and M. Peyronie Although results are comparable to surgical intervention, skin laceration is a severe and relevant side effect. Doxycycline (DOX) recently rose interest as an inhibitor of matrix-metalloproteinases alongside its capabilities of skin accumulation. It therefore might be a potential skin protective agent in the use of CCH.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>For simulation of a fibroproliferative disease adjacent to the skin, we utilized a rodent model of capsular fibrosis involving silicone implants and subsequent fibrotic capsule formation. For in-vitro studies, fibrotic capsules were excised and incubated with 0.9 mg\/ml CCH and four different doses of DOX. For in-vivo experiments, animals received 0.0, 0.3 or 0.9 mg\/ml CCH injections into the fibrotic capsules with or without prior oral DOX administration. Outcome analysis included histology, immunohistochemistry, gene expression analysis, chemical collagen and DOX concentration measurements as well as \u03bcCT imaging.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>In-vitro, DOX showed a dose-dependent inhibition of CCH activity associated with increasing capsule thickness and collagen density and content. In-vivo, oral DOX administration did neither interfere with capsule formation nor in effectiveness of CCH dissolving fibrotic capsule tissue. However, skin thickness and especially collagen density was significantly higher compared to control groups. This led to a reduced rate of clinical skin lacerations after DOX administration.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>DOX inhibits CCH and accumulates in the skin. Thereby, DOX can effectively reduce skin laceration after CCH treatment.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0270112","type":"journal-article","created":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:37:24Z","timestamp":1657129044000},"page":"e0270112","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Oral doxycycline prevents skin-associated adverse effects induced by injectable collagenase in a rodent model of capsular contracture around silicone implants"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8073-3009","authenticated-orcid":true,"given":"Yannick F.","family":"Diehm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Kotsougiani-Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Porst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Haug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Siegwart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Overhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3402-2860","authenticated-orcid":true,"given":"Ulrich","family":"Kneser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3445-1902","authenticated-orcid":true,"given":"Sebastian","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"issue":"12","key":"pone.0270112.ref001","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/j.jhsa.2010.08.007","article-title":"Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren\u2019s disease.","volume":"35","author":"D Gilpin","year":"2010","journal-title":"The Journal of hand surgery"},{"issue":"3","key":"pone.0270112.ref002","doi-asserted-by":"crossref","first-page":"497e","DOI":"10.1097\/PRS.0000000000000433","article-title":"Collagenase Clostridium histolyticum injection for plantar fibromatosis (Ledderhose disease).","volume":"134","author":"ZS Hammoudeh","year":"2014","journal-title":"Plastic and reconstructive surgery"},{"issue":"5","key":"pone.0270112.ref003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1177\/1753193413488305","article-title":"Surgical findings in the treatment of Dupuytren\u2019s disease after initial treatment with clostridial collagenase (Xiaflex).","volume":"39","author":"DC Hay","year":"2014","journal-title":"The Journal of hand surgery, European volume."},{"issue":"3","key":"pone.0270112.ref004","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11552-012-9424-2","article-title":"What were the adverse events for Dupuytren\u2019s patients treated with Xiaflex who had contractures less than 20 degrees?","volume":"7","author":"MF Freshwater","year":"2012","journal-title":"Hand (New York, NY)."},{"issue":"1","key":"pone.0270112.ref005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/jsm.12731","article-title":"Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie\u2019s disease: a phase 3 open-label study","volume":"12","author":"LA Levine","year":"2015","journal-title":"The journal of sexual medicine"},{"issue":"4443","key":"pone.0270112.ref006","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/1741191a0","article-title":"Separation of proteolytic enzymes of Clostridium histolyticum","volume":"174","author":"R Debellis","year":"1954","journal-title":"Nature"},{"issue":"9","key":"pone.0270112.ref007","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1128\/JB.181.9.2816-2822.1999","article-title":"Identification of metal ligands in the Clostridium histolyticum ColH collagenase","volume":"181","author":"CM Jung","year":"1999","journal-title":"Journal of bacteriology"},{"issue":"12","key":"pone.0270112.ref008","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1172\/JCI102860","article-title":"Bacterial digestion of collagen","volume":"32","author":"JD Maclennan","year":"1953","journal-title":"The Journal of clinical investigation"},{"key":"pone.0270112.ref009","first-page":"107","article-title":"Role of collagenase clostridium histolyticum in Peyronie\u2019s disease.","volume":"9","author":"TC Peak","year":"2015","journal-title":"Biologics: targets & therapy."},{"issue":"2","key":"pone.0270112.ref010","doi-asserted-by":"crossref","first-page":"e31430","DOI":"10.1371\/journal.pone.0031430","article-title":"In vitro study of novel collagenase (XIAFLEX\u00ae) on Dupuytren\u2019s disease fibroblasts displays unique drug related properties.","volume":"7","author":"F Syed","year":"2012","journal-title":"PloS one."},{"issue":"5","key":"pone.0270112.ref011","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/2000656X.2016.1159568","article-title":"Collagenase Clostridium histolyticum: emerging practice patterns and treatment advances","volume":"50","author":"D Warwick","year":"2016","journal-title":"Journal of plastic surgery and hand surgery"},{"issue":"26","key":"pone.0270112.ref012","first-page":"2579","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"LA Holzer","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"3","key":"pone.0270112.ref013","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.urology.2015.06.013","article-title":"Collagenase Clostridium histolyticum (Xiaflex) for the Treatment of Urethral Stricture Disease in a Rat Model of Urethral Fibrosis.","volume":"86","author":"P Sangkum","year":"2015","journal-title":"Urology"},{"issue":"3","key":"pone.0270112.ref014","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00266-018-1267-y","article-title":"The Collagenase of the Bacterium Clostridium histolyticum in the Treatment of Irradiation-Induced Capsular Contracture.","volume":"43","author":"YF Diehm","year":"2019","journal-title":"Aesthetic plastic surgery"},{"key":"pone.0270112.ref015","article-title":"The Treatment of Capsular Contracture Around Breast Implants Induced by Fractionated Irradiation: The Collagenase of the Bacterium Clostridium Histolyticum as a Novel Therapeutic Approach.","author":"YF Diehm","year":"2020","journal-title":"Aesthetic plastic surgery"},{"key":"pone.0270112.ref016","article-title":"Long-Term Effects of the Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis After Silicone Implants.","author":"S Fischer","year":"2016","journal-title":"Aesthetic plastic surgery"},{"issue":"5","key":"pone.0270112.ref017","doi-asserted-by":"crossref","first-page":"e0156428","DOI":"10.1371\/journal.pone.0156428","article-title":"Efficacy and Safety of the Collagenase of the Bacterium Clostridium Histolyticum for the Treatment of Capsular Contracture after Silicone Implants: Ex-Vivo Study on Human Tissue.","volume":"11","author":"S Fischer","year":"2016","journal-title":"PloS one."},{"issue":"5","key":"pone.0270112.ref018","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1097\/PRS.0000000000001698","article-title":"The Collagenase of the Bacterium Clostridium histolyticum for the Treatment of Capsular Fibrosis after Silicone Implants","volume":"136","author":"S Fischer","year":"2015","journal-title":"Plastic and reconstructive surgery"},{"issue":"5","key":"pone.0270112.ref019","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/jhsu.2002.35299","article-title":"Collagen as a clinical target: nonoperative treatment of Dupuytren\u2019s disease.","volume":"27","author":"MA Badalamente","year":"2002","journal-title":"The Journal of hand surgery"},{"issue":"10","key":"pone.0270112.ref020","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1056\/NEJMoa0810866","article-title":"Injectable collagenase clostridium histolyticum for Dupuytren\u2019s contracture","volume":"361","author":"LC Hurst","year":"2009","journal-title":"The New England journal of medicine"},{"issue":"4","key":"pone.0270112.ref021","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhsa.2010.01.003","article-title":"Collagenase injection as nonsurgical treatment of Dupuytren\u2019s disease: 8-year follow-up","volume":"35","author":"AJ Watt","year":"2010","journal-title":"The Journal of hand surgery"},{"key":"pone.0270112.ref022","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2147\/CEOR.S269957","article-title":"Healthcare Costs and Resource Use of Patients with Dupuytren Contracture Treated with Collagenase Clostridium Histolyticum or Fasciectomy: A Propensity Matching Analysis.","volume":"12","author":"V Zah","year":"2020","journal-title":"Clinicoecon Outcomes Res."},{"issue":"2","key":"pone.0270112.ref023","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/1753193414528843","article-title":"Safety and tolerability of collagenase Clostridium histolyticum and fasciectomy for Dupuytren\u2019s contracture","volume":"40","author":"CA Peimer","year":"2015","journal-title":"The Journal of hand surgery, European volume."},{"key":"pone.0270112.ref024","first-page":"69","volume-title":"Inhibition and Activity Regulation of Bacterial Collagenases.","author":"E Sch\u00f6nauer","year":"2017"},{"issue":"5","key":"pone.0270112.ref025","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2460\/ajvr.79.5.555","article-title":"Comparison of the efficacy of various concentrations and combinations of serum, ethylenediaminetetraacetic acid, tetracycline, doxycycline, minocycline, and N-acetylcysteine for inhibition of collagenase activity in an in vitro corneal degradation model","volume":"79","author":"BA Kimmitt","year":"2018","journal-title":"American journal of veterinary research"},{"issue":"3","key":"pone.0270112.ref026","first-page":"532","article-title":"Oral administration of doxycycline reduces collagenase and gelatinase activities in extracts of human osteoarthritic cartilage","volume":"25","author":"GN Smith","year":"1998","journal-title":"The Journal of rheumatology"},{"issue":"2","key":"pone.0270112.ref027","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0378-4347(00)00261-9","article-title":"Simple and reliable method of doxycycline determination in human plasma and biological tissues","volume":"744","author":"B Axisa","year":"2000","journal-title":"Journal of chromatography B, Biomedical sciences and applications."},{"issue":"5","key":"pone.0270112.ref028","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1600-0765.1983.tb00388.x","article-title":"Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action","volume":"18","author":"LM Golub","year":"1983","journal-title":"J Periodontal Res"},{"issue":"1","key":"pone.0270112.ref029","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00266-013-0235-9","article-title":"Pulsed acoustic cellular expression (PACE) reduces capsule formation around silicone implants.","volume":"38","author":"MA Reichenberger","year":"2014","journal-title":"Aesthetic plastic surgery"},{"issue":"7","key":"pone.0270112.ref030","doi-asserted-by":"crossref","first-page":"e0132131","DOI":"10.1371\/journal.pone.0132131","article-title":"Silicone Implants with Smooth Surfaces Induce Thinner but Denser Fibrotic Capsules Compared to Those with Textured Surfaces in a Rodent Model.","volume":"10","author":"S Fischer","year":"2015","journal-title":"PloS one."},{"issue":"6","key":"pone.0270112.ref031","first-page":"624","article-title":"The Laboratory Rat: Relating Its Age With Human\u2019s.","volume":"4","author":"P. Sengupta","year":"2013","journal-title":"Int J Prev Med."},{"issue":"2","key":"pone.0270112.ref032","doi-asserted-by":"crossref","first-page":"e0116071","DOI":"10.1371\/journal.pone.0116071","article-title":"Comparison of the postoperative incidence rate of capsular contracture among different breast implants: a cumulative meta-analysis.","volume":"10","author":"X Liu","year":"2015","journal-title":"PloS one."},{"key":"pone.0270112.ref033","unstructured":"Scientific T. Safety Datasheet Doxycycline hyclate; https:\/\/www.alfa.com\/en\/msds\/?language=DE&subformat=CLP1&sku=J60579. 2019."},{"issue":"2","key":"pone.0270112.ref034","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences.","volume":"39","author":"F Faul","year":"2007","journal-title":"Behavior research methods."},{"issue":"1","key":"pone.0270112.ref035","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/10717549609031379","article-title":"Enzyme injection as a nonoperative treatment for Dupuytren\u2019s disease","volume":"3","author":"MA Badalamente","year":"1996","journal-title":"Drug delivery"},{"issue":"3","key":"pone.0270112.ref036","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00255956","article-title":"Collagenase for Peyronie\u2019s disease experimental studies","volume":"10","author":"MK Gelbard","year":"1982","journal-title":"Urol Res"},{"issue":"2","key":"pone.0270112.ref037","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/00007691-198206000-00001","article-title":"Doxycycline.","volume":"4","author":"BA Cunha","year":"1982","journal-title":"Ther Drug Monit"},{"issue":"1","key":"pone.0270112.ref038","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies","volume":"190","author":"M Gelbard","year":"2013","journal-title":"The Journal of urology"},{"issue":"6","key":"pone.0270112.ref039","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1016\/j.juro.2012.01.032","article-title":"Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease","volume":"187","author":"M Gelbard","year":"2012","journal-title":"The Journal of urology"},{"issue":"8","key":"pone.0270112.ref040","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jhsa.2015.04.036","article-title":"Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.","volume":"40","author":"CA Peimer","year":"2015","journal-title":"The Journal of hand surgery"},{"key":"pone.0270112.ref041","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00003086-197110000-00026","article-title":"Experimental intervertebral discolysis. A critique of collagenase and chymopapain applications","volume":"80","author":"BJ Sussman","year":"1971","journal-title":"Clinical orthopaedics and related research"},{"issue":"7","key":"pone.0270112.ref042","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1001\/jama.1981.03310320052026","article-title":"Injection of collagenase in the treatment of herniated lumbar disk. Initial clinical report","volume":"245","author":"BJ Sussman","year":"1981","journal-title":"Jama"},{"issue":"11","key":"pone.0270112.ref043","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.addr.2007.07.004","article-title":"Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models","volume":"59","author":"B Godin","year":"2007","journal-title":"Advanced drug delivery reviews"},{"issue":"9","key":"pone.0270112.ref044","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1191\/0960327104ht471oa","article-title":"A comparison between in vitro rat and human and in vivo rat skin absorption studies","volume":"23","author":"B van Ravenzwaay","year":"2004","journal-title":"Human & experimental toxicology"},{"issue":"5","key":"pone.0270112.ref045","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0021-9258(17)34870-6","article-title":"Human skin collagen. Presence of type I and type III at all levels of the dermis","volume":"253","author":"EH Epstein","year":"1978","journal-title":"The Journal of biological chemistry"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270112","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T17:38:05Z","timestamp":1657129085000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0270112"}},"subtitle":[],"editor":[{"given":"David Benjamin","family":"Lumenta","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":45,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0270112","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,7,6]]}}}